Victory Pharma, San Diego, which sold all of its assets last year, has entered into an $11.4 million settlement with the U.S. Justice Department to resolve allegations that it used pricey trips, tickets and dinners to entice physicians to prescribe its products.
The Justice Department has made fraud and abuse a key area of focus under the Obama administration, collecting more than $4.9 billion in the fiscal year ended Sept. 30. The Victory Pharma agreement comes on the heels of two high-dollar settlements. Last week, biotech giant Amgen agreed to pay $762 million over its marketing of the anemia drug Aranesp, and drugmaker Sanofi US agreed to pay $109 million to resolve anti-kickback allegations relating to its marketing practices.
Victory Pharma no longer does business after selling its nine marketed products in July 2011 to Shionogi & Co., based in Osaka, Japan.